DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Andrews LP, Marciscano AE, Drake CG. et al.
LAG3 (CD223) as a cancer immunotherapy target.
Immunological reviews 2017;
276: 80-96
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.